Perrigo (PRGO) Capital Expenditures (2013 - 2026)

Perrigo's (PRGO) quarterly Capital Expenditures came in at $13.8 million in Q1 2026, down 45.88% year-on-year from $25.5 million in Q1 2025, and down 48.51% on a QoQ basis from $26.8 million in Q4 2025.

Perrigo (PRGO) Capital Expenditures (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Capital Expenditures data on file, last reported at $13.8 million in Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 45.88% year-over-year to $13.8 million in Q1 2026; TTM through Mar 2026 was $81.7 million, a 31.17% decrease from a year earlier, with the FY2025 full-year figure at $93.4 million, down 21.05% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $13.8 million, down from $26.8 million in the prior quarter.
  • Over the last five years, Capital Expenditures for PRGO reached as high as $86.1 million in Q4 2022 and fell as low as -$38.4 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $24.9 million across 5 years, with a median of $25.5 million in 2025.
  • Across the five-year window, Capital Expenditures slumped 1845.45% in 2022 and jumped 182.81% in 2023, its largest moves.
  • Year by year, Capital Expenditures stood at $86.1 million in 2022, then sank by 68.99% to $26.7 million in 2023, then surged by 41.2% to $37.7 million in 2024, then declined by 28.91% to $26.8 million in 2025, then tumbled by 48.51% to $13.8 million in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $13.8 million in Q1 2026, $26.8 million in Q4 2025, and $21.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn 13.80 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 13.80 Mn
Mar 28, 2026 13.80 Mn
Dec 31, 2025 26.80 Mn
Dec 31, 2025 26.80 Mn
Sep 27, 2025 21.90 Mn
Sep 27, 2025 21.90 Mn
Jun 28, 2025 19.20 Mn
Jun 28, 2025 19.20 Mn
Mar 29, 2025 25.50 Mn
Mar 29, 2025 25.50 Mn
Dec 31, 2024 37.70 Mn
Dec 31, 2024 37.70 Mn
Sep 28, 2024 27.10 Mn
Sep 28, 2024 27.10 Mn
Jun 29, 2024 28.40 Mn
Jun 29, 2024 28.40 Mn
Mar 30, 2024 25.10 Mn
Mar 30, 2024 25.10 Mn
Dec 31, 2023 26.70 Mn
Dec 31, 2023 26.70 Mn